NO312056B1 - Anvendelse av preparater til forebygging og behandling av parasitter hos fisk - Google Patents

Anvendelse av preparater til forebygging og behandling av parasitter hos fisk Download PDF

Info

Publication number: NO312056B1
Authority: NO; Norway
Prior art keywords: fish; preparation; salmon; lice; hexaflumuron
Prior art date: 1998-06-09

Application number

NO19982650A

Other languages

English (en)

Norwegian (no)

Other versions

NO982650D0 (no

NO982650L (no

Inventor

Svein Alexandersen

Bernt Martinsen

Oeystein Evensen

Christian Syvertsen

Original Assignee

Alpharma As Aquatic Animal Hea

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-09

Filing date

1998-06-09

Publication date

2002-03-11

1998-06-09 Application filed by Alpharma As Aquatic Animal Hea filed Critical Alpharma As Aquatic Animal Hea

1998-06-09 Priority to NO19982650A priority Critical patent/NO312056B1/no

1998-06-09 Publication of NO982650D0 publication Critical patent/NO982650D0/no

1999-05-31 Priority to AU38412/99A priority patent/AU3841299A/en

1999-05-31 Priority to AT99921041T priority patent/ATE249226T1/de

1999-05-31 Priority to PCT/IB1999/000966 priority patent/WO1999063824A2/en

1999-05-31 Priority to CA002616765A priority patent/CA2616765C/en

1999-05-31 Priority to EP03075182.0A priority patent/EP1306084B1/de

1999-05-31 Priority to ES03075182T priority patent/ES2436040T3/es

1999-05-31 Priority to EP99921041A priority patent/EP1083907B1/de

1999-05-31 Priority to CA002334675A priority patent/CA2334675C/en

1999-05-31 Priority to DE69911204T priority patent/DE69911204D1/de

1999-12-10 Publication of NO982650L publication Critical patent/NO982650L/no

2000-12-05 Priority to DKPA200001822A priority patent/DK176987B1/da

2002-03-11 Publication of NO312056B1 publication Critical patent/NO312056B1/no

2008-03-25 Priority to DK200800436A priority patent/DK200800436A/da

Links

241000251468 Actinopterygii Species 0.000 title claims abstract description 89
238000011282 treatment Methods 0.000 title claims abstract description 44
244000045947 parasite Species 0.000 title claims abstract description 41
238000002360 preparation method Methods 0.000 title claims description 34
230000002265 prevention Effects 0.000 title 1
241001674048 Phthiraptera Species 0.000 claims abstract description 71
239000000126 substance Substances 0.000 claims abstract description 36
239000000203 mixture Substances 0.000 claims abstract description 27
238000002347 injection Methods 0.000 claims abstract description 26
239000007924 injection Substances 0.000 claims abstract description 26
229960005486 vaccine Drugs 0.000 claims abstract description 21
229920002101 Chitin Polymers 0.000 claims abstract description 20
230000015572 biosynthetic process Effects 0.000 claims abstract description 16
238000003786 synthesis reaction Methods 0.000 claims abstract description 15
239000005912 Lufenuron Substances 0.000 claims abstract description 10
PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 claims abstract description 10
229960000521 lufenuron Drugs 0.000 claims abstract description 10
239000003112 inhibitor Substances 0.000 claims abstract description 8
235000019688 fish Nutrition 0.000 claims description 88
241000972773 Aulopiformes Species 0.000 claims description 61
235000019515 salmon Nutrition 0.000 claims description 57
RGNPBRKPHBKNKX-UHFFFAOYSA-N hexaflumuron Chemical compound C1=C(Cl)C(OC(F)(F)C(F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F RGNPBRKPHBKNKX-UHFFFAOYSA-N 0.000 claims description 54
238000009472 formulation Methods 0.000 claims description 22
239000003795 chemical substances by application Substances 0.000 claims description 16
AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 claims description 15
SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 claims description 15
241000238424 Crustacea Species 0.000 claims description 15
229960002418 ivermectin Drugs 0.000 claims description 15
241000277275 Oncorhynchus mykiss Species 0.000 claims description 14
241000277331 Salmonidae Species 0.000 claims description 12
241001247234 Lepeophtheirus salmonis Species 0.000 claims description 11
239000005893 Diflubenzuron Substances 0.000 claims description 9
241000277289 Salmo salar Species 0.000 claims description 9
QQQYTWIFVNKMRW-UHFFFAOYSA-N diflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C=C1 QQQYTWIFVNKMRW-UHFFFAOYSA-N 0.000 claims description 9
229940019503 diflubenzuron Drugs 0.000 claims description 9
241000316146 Salmo trutta trutta Species 0.000 claims description 7
230000002141 anti-parasite Effects 0.000 claims description 7
239000003096 antiparasitic agent Substances 0.000 claims description 7
241001405819 Caligus elongatus Species 0.000 claims description 6
YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 claims description 6
229960004816 moxidectin Drugs 0.000 claims description 6
238000011321 prophylaxis Methods 0.000 claims description 6
239000005885 Buprofezin Substances 0.000 claims description 4
230000001580 bacterial effect Effects 0.000 claims description 4
PRLVTUNWOQKEAI-VKAVYKQESA-N buprofezin Chemical compound O=C1N(C(C)C)\C(=N\C(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-VKAVYKQESA-N 0.000 claims description 4
201000010099 disease Diseases 0.000 claims description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 claims description 4
229960003997 doramectin Drugs 0.000 claims description 4
YOWNVPAUWYHLQX-UHFFFAOYSA-N fluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C(OC=2C(=CC(=CN=2)C(F)(F)F)Cl)=C1 YOWNVPAUWYHLQX-UHFFFAOYSA-N 0.000 claims description 4
229950006719 fluazuron Drugs 0.000 claims description 4
230000003612 virological effect Effects 0.000 claims description 4
208000035143 Bacterial infection Diseases 0.000 claims description 3
208000030852 Parasitic disease Diseases 0.000 claims description 3
239000000427 antigen Substances 0.000 claims description 3
102000036639 antigens Human genes 0.000 claims description 3
108091007433 antigens Proteins 0.000 claims description 3
208000022362 bacterial infectious disease Diseases 0.000 claims description 3
230000001900 immune effect Effects 0.000 claims description 3
CKVMAPHTVCTEMM-ALPQRHTBSA-N milbemycin oxime Chemical compound O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)C(=N/O)/[C@H]3OC\2)O)C[C@H]4C1.C1C[C@H](C)[C@@H](CC)O[C@@]21O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)C(=N/O)/[C@H]3OC\1)O)C[C@H]4C2 CKVMAPHTVCTEMM-ALPQRHTBSA-N 0.000 claims description 3
229940099245 milbemycin oxime Drugs 0.000 claims description 3
241000277288 Salmo trutta Species 0.000 claims 6
241000238586 Cirripedia Species 0.000 claims 4
HRYILSDLIGTCOP-UHFFFAOYSA-N N-benzoylurea Chemical class NC(=O)NC(=O)C1=CC=CC=C1 HRYILSDLIGTCOP-UHFFFAOYSA-N 0.000 claims 2
150000001875 compounds Chemical class 0.000 claims 2
208000036142 Viral infection Diseases 0.000 claims 1
230000009385 viral infection Effects 0.000 claims 1
206010061217 Infestation Diseases 0.000 abstract description 5
230000003071 parasitic effect Effects 0.000 abstract description 3
241001149911 Isopoda Species 0.000 abstract 1
239000007972 injectable composition Substances 0.000 abstract 1
230000000694 effects Effects 0.000 description 15
239000013543 active substance Substances 0.000 description 13
210000003491 skin Anatomy 0.000 description 13
238000002474 experimental method Methods 0.000 description 12
208000015181 infectious disease Diseases 0.000 description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
210000001519 tissue Anatomy 0.000 description 10
239000010775 animal oil Substances 0.000 description 8
238000003287 bathing Methods 0.000 description 8
238000011161 development Methods 0.000 description 7
231100000331 toxic Toxicity 0.000 description 6
230000002588 toxic effect Effects 0.000 description 6
239000005892 Deltamethrin Substances 0.000 description 5
241000124008 Mammalia Species 0.000 description 5
239000005938 Teflubenzuron Substances 0.000 description 5
229960002483 decamethrin Drugs 0.000 description 5
OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 5
239000000839 emulsion Substances 0.000 description 5
230000029142 excretion Effects 0.000 description 5
238000009313 farming Methods 0.000 description 5
239000013505 freshwater Substances 0.000 description 5
210000003205 muscle Anatomy 0.000 description 5
CJDWRQLODFKPEL-UHFFFAOYSA-N teflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(Cl)=C(F)C(Cl)=C1F CJDWRQLODFKPEL-UHFFFAOYSA-N 0.000 description 5
238000002255 vaccination Methods 0.000 description 5
230000008859 change Effects 0.000 description 4
239000003814 drug Substances 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
230000000069 prophylactic effect Effects 0.000 description 4
239000000243 solution Substances 0.000 description 4
230000001225 therapeutic effect Effects 0.000 description 4
241000894006 Bacteria Species 0.000 description 3
206010017553 Furuncle Diseases 0.000 description 3
241000238631 Hexapoda Species 0.000 description 3
VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 3
229940079593 drug Drugs 0.000 description 3
208000003512 furunculosis Diseases 0.000 description 3
210000002816 gill Anatomy 0.000 description 3
239000013642 negative control Substances 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
239000013535 sea water Substances 0.000 description 3
241001148083 Aeromonas salmonicida subsp. salmonicida Species 0.000 description 2
239000005946 Cypermethrin Substances 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
206010047400 Vibrio infections Diseases 0.000 description 2
VNKBTWQZTQIWDV-UHFFFAOYSA-N azamethiphos Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=O)(OC)OC)C2=N1 VNKBTWQZTQIWDV-UHFFFAOYSA-N 0.000 description 2
230000008499 blood brain barrier function Effects 0.000 description 2
210000001218 blood-brain barrier Anatomy 0.000 description 2
229960005424 cypermethrin Drugs 0.000 description 2
KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 2
230000007423 decrease Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
210000000936 intestine Anatomy 0.000 description 2
238000013508 migration Methods 0.000 description 2
230000005012 migration Effects 0.000 description 2
210000003097 mucus Anatomy 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
230000028327 secretion Effects 0.000 description 2
239000000725 suspension Substances 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
241000607525 Aeromonas salmonicida Species 0.000 description 1
241001523601 Gyrodactylus Species 0.000 description 1
GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
241000269951 Labridae Species 0.000 description 1
241001600139 Moritella viscosa Species 0.000 description 1
206010033799 Paralysis Diseases 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
240000004460 Tanacetum coccineum Species 0.000 description 1
208000035056 Tick-Borne disease Diseases 0.000 description 1
206010070863 Toxicity to various agents Diseases 0.000 description 1
241000607598 Vibrio Species 0.000 description 1
241000544286 Vibrio anguillarum Species 0.000 description 1
ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 1
229950001327 dichlorvos Drugs 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
210000003608 fece Anatomy 0.000 description 1
230000037406 food intake Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
150000002596 lactones Chemical class 0.000 description 1
230000004807 localization Effects 0.000 description 1
231100000053 low toxicity Toxicity 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
230000036244 malformation Effects 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000000034 method Methods 0.000 description 1
229960001952 metrifonate Drugs 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
230000036281 parasite infection Effects 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
231100000572 poisoning Toxicity 0.000 description 1
230000000607 poisoning effect Effects 0.000 description 1
230000002028 premature Effects 0.000 description 1
238000009117 preventive therapy Methods 0.000 description 1
229940015367 pyrethrum Drugs 0.000 description 1
238000011160 research Methods 0.000 description 1
230000000630 rising effect Effects 0.000 description 1
238000005070 sampling Methods 0.000 description 1
238000003307 slaughter Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
208000016523 tick-borne infectious disease Diseases 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000018405 transmission of nerve impulse Effects 0.000 description 1
230000032258 transport Effects 0.000 description 1
NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 description 1
210000001835 viscera Anatomy 0.000 description 1
230000003313 weakening effect Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/28—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
- A01N47/34—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< containing the groups, e.g. biuret; Thio analogues thereof; Urea-aldehyde condensation products
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Dentistry (AREA)
General Chemical & Material Sciences (AREA)
Plant Pathology (AREA)
Pest Control & Pesticides (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Environmental Sciences (AREA)
Tropical Medicine & Parasitology (AREA)
Agronomy & Crop Science (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Farming Of Fish And Shellfish (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO19982650A 1998-06-09 1998-06-09 Anvendelse av preparater til forebygging og behandling av parasitter hos fisk NO312056B1 (no)

Priority Applications (12)

Application Number	Priority Date	Filing Date	Title
NO19982650A NO312056B1 (no)	1998-06-09	1998-06-09	Anvendelse av preparater til forebygging og behandling av parasitter hos fisk
DE69911204T DE69911204D1 (de)	1998-06-09	1999-05-31	Bekämpfung von parasitischen befallen in fischen
ES03075182T ES2436040T3 (es)	1998-06-09	1999-05-31	Composición para el control de infestaciones parasitarias en peces
AT99921041T ATE249226T1 (de)	1998-06-09	1999-05-31	Bekämpfung von parasitischen befallen in fischen
PCT/IB1999/000966 WO1999063824A2 (en)	1998-06-09	1999-05-31	Control of parasitic infestations in farmed and wild fish
CA002616765A CA2616765C (en)	1998-06-09	1999-05-31	Control of parasitic infestations in farmed and wild fish
EP03075182.0A EP1306084B1 (de)	1998-06-09	1999-05-31	Zusammensetzungen zur Bekämpfung von parasitischen Befallen in Fischen
AU38412/99A AU3841299A (en)	1998-06-09	1999-05-31	Control of parasitic infestations in farmed and wild fish
EP99921041A EP1083907B1 (de)	1998-06-09	1999-05-31	Bekämpfung von parasitischen befallen in fischen
CA002334675A CA2334675C (en)	1998-06-09	1999-05-31	Control of parasitic infestations in farmed and wild fish
DKPA200001822A DK176987B1 (da)	1998-06-09	2000-12-05	Kontrol af parasitinfestationer hos opdrættede og vilde fisk
DK200800436A DK200800436A (da)	1998-06-09	2008-03-25	Kontrol af parasitinfektioner hos opdrættede og vilde fisk

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
NO19982650A NO312056B1 (no)	1998-06-09	1998-06-09	Anvendelse av preparater til forebygging og behandling av parasitter hos fisk

Publications (3)

Publication Number	Publication Date
NO982650D0 NO982650D0 (no)	1998-06-09
NO982650L NO982650L (no)	1999-12-10
NO312056B1 true NO312056B1 (no)	2002-03-11

Family

ID=19902134

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19982650A NO312056B1 (no)	1998-06-09	1998-06-09	Anvendelse av preparater til forebygging og behandling av parasitter hos fisk

Country Status (9)

Country	Link
EP (2)	EP1083907B1 (de)
AT (1)	ATE249226T1 (de)
AU (1)	AU3841299A (de)
CA (2)	CA2616765C (de)
DE (1)	DE69911204D1 (de)
DK (2)	DK176987B1 (de)
ES (1)	ES2436040T3 (de)
NO (1)	NO312056B1 (de)
WO (1)	WO1999063824A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO333479B1 (no) *	2012-02-09	2013-06-24	Calanus As	Fluidpermeabelt beskyttelsesnett for oppdrettsmerd

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6538031B1 (en)	1999-11-25	2003-03-25	Novartis Animal Health Us, Inc.	Method of controlling sea lice infestation in fish
GB2517588B (en) *	2012-02-09	2018-12-12	Salgard As	Device For Fish Farm Cage
DK179072B1 (da)	2012-05-08	2017-10-09	Novartis Tiergesundheit Ag	Ny Behandling
NO342352B1 (no) *	2012-05-14	2018-05-07	Previwo As	Fiske vaksine
EP2877027A1 (de)	2012-07-27	2015-06-03	Novartis Tiergesundheit AG	Neue behandlung von fischen mit einer nanosuspension aus lufenuron oder hexaflumuron
NO338812B1 (no) *	2013-09-27	2016-10-24	Lutra As	System for badebehandling av fisk infisert med en ekstern fiskeparasitt og framgangsmåte for bruk av kaliumklorid som behandlingsmiddel i systemet
US9770024B2 (en)	2013-10-01	2017-09-26	Investfood, LLC	Use of propyl propane thiosulfinate and propyl propane thiosulfonate for the prevention and reduction of parasites in aquatic animals
US9271947B2 (en)	2013-10-01	2016-03-01	Investfood, LLC	Use of propyl propane thiosulfinate and propyl propane thiosulfonate for the prevention and reduction of parasites in aquatic animals
GB201502611D0 (en) *	2015-02-17	2015-04-01	Hydrolice As	Method of treatment and/or prevention of a sea lice infestation on fish, and compositions for that use
GB201610275D0 (en) *	2016-06-13	2016-07-27	Benchmark Animal Health Ltd	Treatment of marine parasite infection
WO2019245891A1 (en)	2018-06-19	2019-12-26	Pharmaq As	Use of milbemycin oxime against sea lice on fish

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9024928D0 (en) *	1990-11-16	1991-01-02	Beecham Group Plc	Novel treatment
RU2120943C1 (ru) *	1993-10-05	1998-10-27	Пфайзер Инк.	Производные дорамектина, способы их получения, способы лечения
CH687732A5 (de) *	1994-06-09	1997-02-14	Ciba Geigy Ag	Verfahren zur Bekaempfung von Insekten.
US5871751A (en) *	1994-10-12	1999-02-16	The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University	Renibacterium salmoninarum vaccine and method for its preparation
NO179816C (no) *	1995-06-13	1996-12-27	Nutreco Aquaculture Res Centre	Middel for bekjempelse av parasitter hos oppdrettsfisk
US5837734A (en) *	1996-05-01	1998-11-17	Novartis Corporation	Method for the treatment of coccidioidomycosis in warm-blooded animals
CN1217579C (zh) *	1996-05-30	2005-09-07	尤尼罗亚尔化学公司	用于基因改造的Bt棉花的苯甲酰脲杀虫剂
CA2259469A1 (en) *	1996-06-05	1997-12-11	Ashmont Holdings Limited	Injectable compositions
IL124128A (en) *	1998-03-02	2003-09-17	Yair Ben Ziony	Composition comprising a benzoylphenylurea for treatment of topical fungal infection

1998
- 1998-06-09 NO NO19982650A patent/NO312056B1/no not_active IP Right Cessation
1999
- 1999-05-31 CA CA002616765A patent/CA2616765C/en not_active Expired - Lifetime
- 1999-05-31 DE DE69911204T patent/DE69911204D1/de not_active Expired - Lifetime
- 1999-05-31 WO PCT/IB1999/000966 patent/WO1999063824A2/en active IP Right Grant
- 1999-05-31 AU AU38412/99A patent/AU3841299A/en not_active Abandoned
- 1999-05-31 ES ES03075182T patent/ES2436040T3/es not_active Expired - Lifetime
- 1999-05-31 AT AT99921041T patent/ATE249226T1/de not_active IP Right Cessation
- 1999-05-31 EP EP99921041A patent/EP1083907B1/de not_active Expired - Lifetime
- 1999-05-31 EP EP03075182.0A patent/EP1306084B1/de not_active Expired - Lifetime
- 1999-05-31 CA CA002334675A patent/CA2334675C/en not_active Expired - Lifetime
2000
- 2000-12-05 DK DKPA200001822A patent/DK176987B1/da not_active IP Right Cessation
2008
- 2008-03-25 DK DK200800436A patent/DK200800436A/da not_active Application Discontinuation

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO333479B1 (no) *	2012-02-09	2013-06-24	Calanus As	Fluidpermeabelt beskyttelsesnett for oppdrettsmerd
NO20120133A1 (no) *	2012-02-09	2013-06-24	Calanus As	Fluidpermeabelt beskyttelsesnett for oppdrettsmerd
WO2013117773A2 (en)	2012-02-09	2013-08-15	Calanus As	Device for fish farm cage
US9271477B2 (en)	2012-02-09	2016-03-01	Calanus As	Device for fish farm cage
DK179218B1 (en) *	2012-02-09	2018-02-12	Salgard As	Device for fish farm cage

Also Published As

Publication number	Publication date
EP1083907A2 (de)	2001-03-21
CA2334675C (en)	2009-09-15
ATE249226T1 (de)	2003-09-15
WO1999063824A3 (en)	2000-04-13
EP1306084A1 (de)	2003-05-02
ES2436040T3 (es)	2013-12-26
WO1999063824A8 (en)	2000-02-17
DE69911204D1 (de)	2003-10-16
CA2616765A1 (en)	1999-12-16
NO982650D0 (no)	1998-06-09
CA2334675A1 (en)	1999-12-16
EP1083907B1 (de)	2003-09-10
DK200800436A (da)	2008-03-25
DK176987B1 (da)	2010-09-27
CA2616765C (en)	2009-09-15
WO1999063824A2 (en)	1999-12-16
DK200001822A (da)	2000-12-27
NO982650L (no)	1999-12-10
WO1999063824B1 (en)	2000-05-18
AU3841299A (en)	1999-12-30
EP1306084B1 (de)	2013-08-21

Publication	Publication Date	Title
JP7474912B2 (ja)	2024-04-25	海産魚類に寄生する微胞子虫及び粘液胞子虫による疾患の治療剤
NO312056B1 (no)	2002-03-11	Anvendelse av preparater til forebygging og behandling av parasitter hos fisk
Campbell et al.	1964	Effect of thiabendazole upon the enteral and parenteral phases of trichinosis in mice
Tonguthai	1997	Control of freshwater fish parasites: a Southeast Asian perspective
Kitancharoen et al.	1997	The fungistatic effect of NaCl on rainbow trout egg saprolegniasis
Larrat et al.	2012	Safety and efficacy of emamectin benzoate to treat Anguillicoloides crassus (Kuwahara, Niimi & Itagaki) infections in American eels, Anguilla rostrata (Lesueur).
NO335129B1 (no)	2014-09-22	Anvendelse av neomycin for fremstilling av et medikament for behandling eller forebygging av infeksjon med infeksiøst pankreatisk nekrose virus (IPNV) hos akvatiske dyr
KITANCHAROEN et al.	1998	Effects of sodium chloride, hydrogen peroxide and malachite green on fungal infection in rainbow trout eggs
JP2020096599A (ja)	2020-06-25	低濃度過酸化水素水による魚類外部寄生虫駆除方法
KR100251428B1 (ko)	2000-04-15	양식 물고기용 구충제
CN107920531B (zh)	2020-07-07	用于对抗鱼类寄生虫的试剂
NO322663B1 (no)	2006-11-13	Antiparasittisk preparat til behandling av fisk, samt anvendelse av heksaflumuron ved fremstilling av medikamentelle preparater.
WO2017150988A1 (en)	2017-09-08	Preparation containing sea water added a potassium compound
JP2023078111A (ja)	2023-06-06	グルタルアルデヒドを含む魚類寄生虫駆除剤
Treves-Brown et al.	2000	Ectoparasiticides
KR20030019558A (ko)	2003-03-06	복어류 기생충의 구제제 및 구제방법
DK201970377A1 (en)	2020-01-13	Use of Milbemycin Oxime Against Sea Lice on Fish
Bright Singh et al.	2009	Ornamental fish diseases and their management measures
Bright Singh et al.	2009	Ornamental fish diseases and their management measures-Winter School on Recent Advances in Breeding and Larviculture of Marine Finfish and Shellfish
Tucker et al.	1998	Maintaining healthy marine fish
KR20190007171A (ko)	2019-01-22	실리카 졸을 포함하는 어류의 스쿠티카충 구제용 조성물
JPS6160041B2 (de)	1986-12-19

Legal Events

Date	Code	Title	Description
2015-04-07	CREP	Change of representative	Representative=s name: ONSAGERS AS, POSTBOKS 1813 VIKA, 0123 OSLO, NORGE
2018-07-09	MK1K	Patent expired